Cytochromes P450 and metabolism of xenobiotics

被引:692
作者
Anzenbacher, P
Anzenbacherová, E
机构
[1] Palacky Univ, Fac Med, Inst Pharmacol, Olomouc 77515, Czech Republic
[2] Palacky Univ, Fac Med, Inst Med Chem & Biochem, Olomouc 77515, Czech Republic
关键词
cytochromes P450; CYP; drug metabolism; xenobiotic;
D O I
10.1007/PL00000897
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochromes P450 (henceforth P450s) are involved in a variety of metabolic and biosynthetic processes. The number of known P450 enzymes exceeds 1000, while the endogenous substrates of most of them remain unknown. All P450 enzymes exhibit similarity in their structure and general mechanism of action; however, there are significant differences in the detailed function of individual enzymes as well as in the structures and properties of their active sites. This review discusses the properties of the most important P450 enzymes taking part in drug metabolism in humans. P450 3A4 is of paramount importance, because it is the most abundant P450 in the human liver and is known to metabolize the majority of drugs whose biotransformation is known. Genetically dependent variabilities of individual P450 activities and levels are described, documenting the importance of pharmacogenetics aimed at explaining differences in the response of the organism to various drugs.
引用
收藏
页码:737 / 747
页数:11
相关论文
共 69 条
  • [1] The CYP2D6 extensive metabolizer genotype is associated with increased risk for bladder cancer
    AbdelRahman, SZ
    Anwar, WA
    AbdelAal, WE
    Ghoneim, MA
    Au, WW
    [J]. CANCER LETTERS, 1997, 119 (01) : 115 - 122
  • [2] Selective effect of liver disease on the activities of specific metabolizing enzymes: Investigation of cytochromes P450 2C19 and 2D6
    Adedoyin, A
    Arns, PA
    Richards, WO
    Wilkinson, GR
    Branch, RA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (01) : 8 - 17
  • [3] High conformational stability of cytochrome P-450 1A2. Evidence from UV absorption spectra
    Anzenbacher, P
    Bec, N
    Hudecek, J
    Lange, R
    Anzenbacherova, E
    [J]. COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 1998, 63 (03) : 441 - 448
  • [4] TOWARDS A UNIFIED CONCEPT OF OXYGEN ACTIVATION BY HEME ENZYMES - THE ROLE OF THE PROXIMAL LIGAND
    ANZENBACHER, P
    DAWSON, JH
    KITAGAWA, T
    [J]. JOURNAL OF MOLECULAR STRUCTURE, 1989, 214 : 149 - 158
  • [5] Anzenbacherová E, 2000, INT J CLIN PHARM TH, V38, P426
  • [6] Flexibility and stability of the structure of cytochromes P450 3A4 and BM-3
    Anzenbacherová, E
    Bec, N
    Anzenbacher, P
    Hudecek, J
    Soucek, P
    Jung, C
    Munro, AW
    Lange, R
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (10): : 2916 - 2920
  • [7] BAILEY DG, 1995, CAN J CLIN PHARM, V2, P10
  • [8] Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions
    Bertz, RJ
    Granneman, GR
    [J]. CLINICAL PHARMACOKINETICS, 1997, 32 (03) : 210 - 258
  • [9] LUNG-CANCER AND THE DEBRISOQUINE METABOLIC PHENOTYPE
    CAPORASO, NE
    TUCKER, MA
    HOOVER, RN
    HAYES, RB
    PICKLE, LW
    ISSAQ, HJ
    MUSCHIK, GM
    GREENGALLO, L
    BUIVYS, D
    AISNER, S
    RESAU, JH
    TRUMP, BF
    TOLLERUD, D
    WESTON, A
    HARRIS, CC
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (15) : 1264 - 1272
  • [10] Molecular modeling of mammalian cytochrome P450s
    Dai, R
    Pincus, MR
    Friedman, FK
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (03) : 487 - 499